Food and Drug Administration approves Alzheimer’s drug that slowed cognitive decline in clinical trial
CHARLESTON — More than 6.5 million people in the U.S. suffer from Alzheimer’s disease. The irreversible disease destroys memory, thinking skills, and eventually the ability